The figures from IMS Health did highlight one source of optimism for pharmaceutical companies: The seven countries IMS Health calls the “pharemerging countries”… China, Brazil, India, Russia, Turkey, South Korea and Mexico.
The potential for the pharma companies to increase their revenues is enormous, as these seven markets represent about 45 percent of the world’s population. And there are a half billion people living in these seven “pharemerging markets” that can afford Western medicine.